Breast cancer risk factors and their effects on survival: a Mendelian randomisation study.
Maria Escala-GarciaAnna MorraSander CanisiusJenny Chang-ClaudeSiddhartha KarWei ZhengStig E BojesenDoug EastonPaul D P PharoahMarjanka K SchmidtPublished in: BMC medicine (2020)
This extensive MR analysis suggests that T2DM may be causally associated with worse breast cancer-specific survival and therefore that treating T2DM may improve prognosis.